Cost-effectiveness of Fufang Huangbai fluid versus Suprasorb® A + Ag antimicrobial calcium alginate wound dressing for treating IWGDF/IDSA grade 1–2 diabetic foot ulcers
Evidence-Based Chinese Medicine and Technology Assessment · 2025
DOI: 10.26599/ecmta.2025.9570022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence-Based Chinese Medicine and Technology Assessment, 2025. Verfasst von Yu-chen Gong und 4 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
IntroductionDiabetic foot infections impose a substantial economic burden globally, particularly in developing countries such as China. This study evaluated the cost-effectiveness of Fufang Huangbai fluid (FHF) compared with Suprasorb® A + Ag antimicrobial calcium alginate wound dressing (SAAAD) for treating grade 1–2 diabetic foot ulcers (DFUs) (graded according to the International Working Group on the Diabetic Foot/the Infectious Diseases Society of America [IWGDF/IDSA]). MethodsA cost-effectiveness analysis was conducted using 2 weeks of randomized controlled trial data (n = 176) using Chinese healthcare system costs and service fees. Quality-adjusted life years (QALYs) served as the primary health outcome, and costs included drug expenses and dressing services. Both deterministic and probabilistic sensitivity analyses were performed. ResultsCompared with the SAAAD group, the FHF group saved CNY 300.64 and gained an incremental 0.0013 QALYs, making it a dominant approach with a net monetary benefit of CNY 325.86. Sensitivity analysis indicated that the unit price of SAAAD had the greatest impact on the results. At a willingness-to-pay threshold of CNY 20 000 per QALY, the probability of FHF being cost-effective was 70.65%. ConclusionFHF is economically advantageous compared with SAAAD for the treatment of DFUs of IWGDF/IDSA grade 1–2.
Zitieren
APA
Gong, Y., Wan, C., Tang, P., Xi, X., & Wang, G. (2025). Cost-effectiveness of Fufang Huangbai fluid versus Suprasorb® A + Ag antimicrobial calcium alginate wound dressing for treating IWGDF/IDSA grade 1–2 diabetic foot ulcers. Evidence-Based Chinese Medicine and Technology Assessment. https://doi.org/10.26599/ecmta.2025.9570022
Vancouver
Gong Y, Wan C, Tang P, Xi X, Wang G. Cost-effectiveness of Fufang Huangbai fluid versus Suprasorb® A + Ag antimicrobial calcium alginate wound dressing for treating IWGDF/IDSA grade 1–2 diabetic foot ulcers. Evidence-Based Chinese Medicine and Technology Assessment. 2025. doi:10.26599/ecmta.2025.9570022
BibTeX
@article{Gong2025,
author = {Gong, Yu-chen and Wan, Chu-chuan and Tang, Peng-cheng and Xi, Xiao-yu and Wang, Gang},
title = {Cost-effectiveness of Fufang Huangbai fluid versus Suprasorb® A + Ag antimicrobial calcium alginate wound dressing for treating IWGDF/IDSA grade 1–2 diabetic foot ulcers},
journal = {Evidence-Based Chinese Medicine and Technology Assessment},
year = {2025},
doi = {10.26599/ecmta.2025.9570022}
}
EUVIMED